Major Depression: Clinical Trials

296 trials for Major Depression, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

187 completed, 35 unknown, 27 recruiting, 22 terminated. 134 Not applicable, 50 Phase 4, 36 Phase 2, 21 Phase 3, 18 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable134Completed 90, Recruiting 13, Unknown 12, Terminated 6, Withdrawn 5, Active not recruiting 4, Not yet recruiting 2, Enrolling by invitation 1, Suspended 1
Phase 450Completed 33, Unknown 9, Terminated 8
Phase 236Completed 21, Recruiting 4, Terminated 4, Unknown 4, Not yet recruiting 3
Phase 321Completed 13, Terminated 2, Unknown 2, Withdrawn 2, Not yet recruiting 1, Recruiting 1
Phase 118Completed 13, Recruiting 2, Not yet recruiting 1, Terminated 1, Unknown 1
Early Phase 12Recruiting 2

Follow Major Depression: new trials by email Literature Review of Major Depression trials Research Report on Major Depression

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Psilocybin for Depression in Veterans
Psilocybin, modafinil, zolpidem - Major Depression
Phase 2Not yet recruitingVA Office of Research and Development1502027-01-012026-10-26
Assessing of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies
Transcranial Magnetic Stimulation, Psilocybin (drug), Neurofeedback - PTSD, PTSD - Post Traumatic Stress Disorder
Phase 2Not yet recruitingUniversity of New Mexico1502026-12-312026-10-30
Shortened LSD Intervention for Major Depressive Disorder
LSD, Risperidone - Major Depression Moderate, Major Depression Severe
Phase 1Not yet recruitingJohns Hopkins University102026-12-012026-11-03
EEG-Guided Transcranial Magnetic Stimulation for Adults With Depression
MagVenture TMS Therapy System with Localite Navigation System and actiCHamp EEG - Major Depressive Disorder (MDD), Treatment Resistant Depression
Not applicableRecruitingMayo Clinic602026-11-022026-11-03
Individual Narratives of Stimulation (ECT and TMS)
There is no intervention in this observation study (qualitative interviews about past treatment experiences) - Major Depression
Not yet recruitingUniversity of Nottingham122026-11-012026-09-30
Single Day of Ultra-accelerated TMS With a Single Dose of NRX-101
TMS, NRX-101 - Major Depression
Early Phase 1RecruitingMclean Hospital302026-10-012026-10-30
Synaptic Mechanisms of Intermittent Theta Burst Stimulation for Major Depressive Disorder
Sham iTBS, TMS, D-cycloserine - Major Depression, Healthy Participants
Phase 1 / Phase 2RecruitingMclean Hospital1002026-10-012026-10-30
Evaluation of an 8-week Behavior Skills-based Virtual Reality Program for Adolescents With Depression. (MDD)
Virtual reality - Major Depression
Not applicableNot yet recruitingEdward Via Virginia College of Osteopathic Medicine102026-09-012026-09-08
Relationship of Peripheral Inflammatory and Neuroprotective Biomarkers With Response to Intermittent Theta Burst Stimulation in Treatment-Resistant Depression
Intermittent Theta Burst Stimulation (iTBS) - Treatment-resistant Depression (TRD), Major Depression
Not applicableRecruitingGulhane Training and Research Hospital1002026-09-012026-09-14
Non-Coding RNAs Gene Expression in Psychiatric Disorders
Reverse Transcription Quantitative Polymerase Chain Reaction - Schizophrenia Disorders, Major Depression
Not yet recruitingCarmen Concerto3842026-09-012026-06-23
Neural Mechanisms of Real-world Emotions and Internalizing
Academic Performance Feedback - Major Depression, Generalized Anxiety
Not applicableRecruitingUniversity of Miami1442026-08-242026-10-23
Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
Psilocybin - Major Depression
Phase 3RecruitingVA Office of Research and Development2402026-08-032026-10-23
Inhaled DMT for Major Depressive Disorder
N,N-Dimethyltryptamine (15 mg + 60 mg), N,N-Dimethyltryptamine (1 mg + 4 mg) - MDD, Major Depressive Disorder (MDD)
Phase 2RecruitingUniversidade Federal do Rio Grande do Norte1402026-08-012026-07-13
Study of Psilocybin Under Anesthesia Controlled by EEG
Psilocybin (Usona Institute), Propofol, Placebo - Major Depression
Phase 2Not yet recruitingStanford University102026-07-012026-05-06
iTBS Versus Standard 10 Hz rTMS for Treatment-Resistant Depression (TRD)
iTBS, rTMS - Major Depression
Not applicableActive not recruitingKafrelsheikh University1822026-06-302026-10-01
Study on iTBS Regulating the Reward Circuit Function to Improve Anhedonia in Depression
Left DLPFC + OFC iTBS, Left DLPFC iTBS - Major Depression, Anhedonia
Not applicableRecruitingGuo Wenbin602026-05-192026-09-10
Modular Intervention for Depression Study
Modular Intervention for Depression Therapy (MIND Therapy), Psychotherapy as Usual (TAU) - Major Depression
Not applicableRecruitingPontificia Universidad Catolica de Chile1502026-05-012026-05-12
Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression
D-Cycloserine (DCS), Continuous theta-burst stimulation (cTBS), Transcranial Magnetic Stimulation Sham - Major Depression
Early Phase 1RecruitingMclean Hospital802026-03-112026-05-13
Effect of Psychobiotics With Standard Antiddepressants in Treatment of Major Depressive Disorder
Lactobacillus Helveticus and bifidobacterium Longum, Placebo Capsule(s) - Major Depression
Not applicableRecruitingDr Sadia yasir862026-01-312026-09-30
EEG Microstate Parameters and Neuroinflammatory Biomarkers in Patients With Treatment-Resistant Major Depressive Disorder Receiving ECT
Electroconvulsive Therapy - Major Depression Moderate, Major Depression Severe
RecruitingIstanbul University - Cerrahpasa622026-01-012026-08-05

Showing 20 of 296. Sign in to see all of them.

Narrower conditions

Depressive Disorder, Major (296)  ·  Depression (88)  ·  Bipolar Disorder (39)  ·  Schizophrenia (27)  ·  Anxiety Disorders (26)  ·  Depressive Disorder (18)  ·  Psychotic Disorders (16)  ·  Mental Disorders (14)  ·  Mood Disorders (14)  ·  Dysthymic Disorder (13)  ·  Stress Disorders, Post-Traumatic (13)  ·  Depressive Disorder, Treatment-Resistant (8)  ·  Generalized Anxiety Disorder (8)  ·  Sleep Initiation and Maintenance Disorders (5)  ·  Alcoholism (4)

Broader conditions

Mental Disorders (282)  ·  Mood Disorders (282)  ·  Depressive Disorder (278)  ·  Behavior (95)  ·  Behavioral Symptoms (91)  ·  Bipolar and Related Disorders (39)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (31)  ·  Nervous System Diseases (25)  ·  Pathological Conditions, Signs and Symptoms (20)  ·  Trauma and Stressor Related Disorders (18)  ·  Stress Disorders, Traumatic (13)  ·  Signs and Symptoms (12)  ·  Neurologic Manifestations (11)  ·  Central Nervous System Diseases (9)  ·  Nutritional and Metabolic Diseases (9)

Interventions

Escitalopram (23)  ·  Transcranial Magnetic Stimulation (16)  ·  Sertraline (11)  ·  Cognitive Behavioral Therapy (10)  ·  Transcranial Direct Current Stimulation (9)  ·  Fluoxetine (8)  ·  Ketamine (7)  ·  Bupropion (6)  ·  Duloxetine Hydrochloride (6)  ·  Interpersonal Psychotherapy (6)  ·  Venlafaxine Hydrochloride (6)  ·  Citalopram (5)  ·  Paroxetine (5)  ·  Therapeutics (5)  ·  Cycloserine (4)

Sponsors

National Institute of Mental Health (NIMH) (10)  ·  New York State Psychiatric Institute (8)  ·  The University of New South Wales (8)  ·  Massachusetts General Hospital (7)  ·  Centre for Addiction and Mental Health (5)  ·  Charite University, Berlin, Germany (5)  ·  University of Pittsburgh (5)  ·  VA Office of Research and Development (5)  ·  Weill Medical College of Cornell University (5)  ·  Emory University (4)  ·  Hillerod Hospital, Denmark (4)  ·  Karolinska Institutet (4)  ·  Mclean Hospital (4)  ·  US Department of Veterans Affairs (4)  ·  University of California, Los Angeles (4)

Countries

United States (130)  ·  Canada (21)  ·  Germany (21)  ·  France (14)  ·  Australia (10)  ·  Denmark (10)  ·  Israel (10)  ·  China (8)  ·  Sweden (8)  ·  Brazil (6)  ·  Norway (6)  ·  Taiwan (5)  ·  Turkey (Türkiye) (5)  ·  Spain (4)  ·  Chile (3)

Top investigators

Carlos A Zarate, M.D. (4)  ·  Amit Anand, MD (3)  ·  Jonathan W. Stewart, MD. (3)  ·  Thomas E. Schlaepfer, MD (3)  ·  Benjamin Van Voorhees, MD, MPH (2)  ·  Christian Otte, MD (2)  ·  Colleen Loo, MBBS, FRANZCP, MD (2)  ·  Dominique Malauzat, MD (2)  ·  Dunja Hinze-Selch, MD (2)  ·  Gordon B Parker, Dsc MD PhD (2)  ·  John D Matthews, MD (2)  ·  Joshua C Brown, MD, PhD (2)  ·  Lisa V. Rubenstein, MD MSPH (2)  ·  Volker Coenen, MD (2)  ·  Aaron S Heller, PhD (1)

Results publications

PMID 34817851, PMID 17503104, PMID 18279507, PMID 19101777, PMID 30253883, PMID 42171126, PMID 11939866, PMID 12472325, PMID 15067160, PMID 15213794, PMID 15365580, PMID 15876903, PMID 16174141, PMID 16677714, PMID 16836631, PMID 16862248, PMID 16946178, PMID 17264696, PMID 17299509, PMID 17365393, PMID 17548749, PMID 17623814, PMID 17702053, PMID 18061147, PMID 18678695, PMID 19061681, PMID 19117524, PMID 19146566, PMID 19193344, PMID 19194795, PMID 19211468, PMID 19264942, PMID 19288975, PMID 19414708, PMID 19545857, PMID 19785754, PMID 19820552, PMID 19892408, PMID 19995444, PMID 20144692, PMID 20157139, PMID 20187924, PMID 20331933, PMID 20367694, PMID 20695669, PMID 21672502, PMID 21731830, PMID 21764215, PMID 21975821, PMID 22032247

NIH funding

2009 (2), R01MH077210 (2), 2005 (1), 2014 (1), I01RD001520 (1), K23MH069784 (1), K99MH141192 (1), M01RR000071 (1), P30MH082760 (1), P30MH090333 (1), R00AA024142 (1), R01CA105269 (1), R01DK103769 (1), R01HL071992 (1), R01MH056946 (1)